Global Pituitary ACTH Hypersecretion Drug Market Study 2016-2026, by Segment (AT-814, ATR-101, … …), by Market (Clinic, Hospital, … …), by Company (Alder Biopharmaceuticals Inc., Corcept Therapeutics Incorporated, … …)
SKU ID :99ST-14636128 | Published Date: 26-Oct-2019 | No. of pages: 51Description
Summary
The global Pituitary ACTH Hypersecretion Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
AT-814
ATR-101
BIM-23A758
COR-005
CORT-125134
ISIS-GCCRRx
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinic
Hospital
Others
Alder Biopharmaceuticals Inc.
Corcept Therapeutics Incorporated
Cortendo AB
Cyclacel Pharmaceuticals, Inc.
ElexoPharm GmbH
Ipsen S.A.
Isis Pharmaceuticals, Inc.
Novartis AG
Orphagen Pharmaceuticals, Inc.
Pfizer Inc.
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Pituitary ACTH Hypersecretion Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
AT-814
ATR-101
BIM-23A758
COR-005
CORT-125134
ISIS-GCCRRx
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Clinic
Hospital
Others
Company Coverage (Sales data, Main Products & Services etc.):
Alder Biopharmaceuticals Inc.
Corcept Therapeutics Incorporated
Cortendo AB
Cyclacel Pharmaceuticals, Inc.
ElexoPharm GmbH
Ipsen S.A.
Isis Pharmaceuticals, Inc.
Novartis AG
Orphagen Pharmaceuticals, Inc.
Pfizer Inc.
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now